Report overview
Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
This report contains market size and forecasts of Beta-Nicotinamide Mononucleotide (NMN) in global, including the following market information:
Global Beta-Nicotinamide Mononucleotide (NMN) Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Sales, 2018-2023, 2023-2030, (Kg)
Global top five Beta-Nicotinamide Mononucleotide (NMN) companies in 2022 (%)
The global Beta-Nicotinamide Mononucleotide (NMN) market was valued at 264.2 million in 2022 and is projected to reach US$ 911.8 million by 2030, at a CAGR of 19.4% during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Content Greater than or Equal to 98% Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Beta-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway. etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Beta-Nicotinamide Mononucleotide (NMN) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Beta-Nicotinamide Mononucleotide (NMN) Market, by Purity, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Segment Percentages, by Purity, 2022 (%)
Content Greater than or Equal to 98%
Content Less than 98%
Global Beta-Nicotinamide Mononucleotide (NMN) Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Segment Percentages, by Application, 2022 (%)
Health Care Products
Cosmetics
Others
Global Beta-Nicotinamide Mononucleotide (NMN) Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Beta-Nicotinamide Mononucleotide (NMN) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Beta-Nicotinamide Mononucleotide (NMN) revenues share in global market, 2022 (%)
Key companies Beta-Nicotinamide Mononucleotide (NMN) sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Beta-Nicotinamide Mononucleotide (NMN) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
